Simplex Trading’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,647
Closed -$19.5K 9600
2025
Q1
$21K Buy
+2,647
New +$19.4K ﹤0.01% 6553
2024
Q2
Sell
-37,954
Closed -$486K 9670
2024
Q1
$711K Buy
37,954
+30,499
+409% +$703K ﹤0.01% 3478
2023
Q4
$161K Buy
+7,455
New +$148K ﹤0.01% 4889
2023
Q3
Sell
-2,562
Closed -$74K 9670
2023
Q2
$120K Buy
+2,562
New +$127K ﹤0.01% 4861
2022
Q3
Sell
-17,320
Closed -$669K 10763
2022
Q2
$559K Sell
17,320
-4,609
-21% -$154K ﹤0.01% 3313
2022
Q1
$725K Buy
21,929
+16,146
+279% +$607K ﹤0.01% 3347
2021
Q4
$246K Sell
5,783
-6,896
-54% -$289K ﹤0.01% 4871
2021
Q3
$727K Buy
12,679
+8
+0.1% +$367 ﹤0.01% 3543
2021
Q2
$719K Sell
12,671
-22,802
-64% -$1.61M ﹤0.01% 3613
2021
Q1
$2.65M Buy
35,473
+31,751
+853% +$2.6M ﹤0.01% 1323
2020
Q4
$321K Buy
3,722
+2,627
+240% +$194K ﹤0.01% 3984
2020
Q3
$66K Buy
+1,095
New +$55.5K ﹤0.01% 5355
2020
Q2
Sell
-10,779
Closed -$391K 8260
2020
Q1
$309K Buy
+10,779
New +$624K ﹤0.01% 3126
2019
Q4
Sell
-3,632
Closed -$447K 7881
2019
Q3
$509K Buy
3,632
+1,414
+64% +$237K ﹤0.01% 2604
2019
Q2
$406K Buy
+2,218
New +$378K ﹤0.01% 2769
2018
Q4
Sell
-2,499
Closed -$286K 7696
2018
Q3
$352K Sell
2,499
-1,156
-32% -$178K ﹤0.01% 2987
2018
Q2
$572K Buy
3,655
+3,332
+1,032% +$523K ﹤0.01% 2326
2018
Q1
$52K Sell
323
-838
-72% -$142K ﹤0.01% 2407
2017
Q4
$191K Sell
1,161
-20,777
-95% -$2.01M 0.01% 1311
2017
Q3
$1.37M Buy
21,938
+12,680
+137% +$996K 0.06% 279
2017
Q2
$737K Buy
9,258
+7,812
+540% +$565K 0.03% 480
2017
Q1
$102K Sell
1,446
-1,077
-43% -$63.1K ﹤0.01% 1735
2016
Q4
$128K Sell
2,523
-461
-15% -$21.7K 0.01% 1340
2016
Q3
$137K Sell
2,984
-24,986
-89% -$1.02M 0.01% 1303
2016
Q2
$842K Buy
+27,970
New +$933K 0.06% 333
2015
Q4
Sell
-4,891
Closed -$206K 6038
2015
Q3
$206K Buy
4,891
+2,285
+88% +$141K 0.02% 892
2015
Q2
$190K Buy
+2,606
New +$168K 0.02% 822

Other funds holding SAGE